Ariadne Genomics - Ownership and Business Overview

Life ScienceCompany

Ariadne Genomics Ownership

Who owns Ariadne Genomics?

Ariadne Genomics is owned by Elsevier BV. It was acquired on December 8, 2011.

Ariadne Genomics Business Overview

Where is Ariadne Genomics headquartered?

Ariadne Genomics is headquartered in Rockville, Maryland.

What sector is Ariadne Genomics in?

Ariadne Genomics is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Ariadne Genomics, Inc.

9430 Key West Avenue Suite 113,
Rockville, Maryland 20850
United States,
(240) 453-6296
www.ariadnegenomics.com

Ariadne Genomics, Inc. is a provider of pathway analysis tools and semantic technologies for pharmaceutical and life science researchers.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.